Quality. Compassion. Care.

Slides:



Advertisements
Similar presentations
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled.
Advertisements

April 28, Atlas Copco Group Q1 Results April 28, 2010.
Atlas Copco Group Q2 Results July 16, Contents  Q2 business highlights  Market development  Business areas  Financials  Outlook 2 July 16,
July 18, 2008, Atlas Copco Group Q2 Results July 18, 2008.
Georg Brunstam President and CEO Per-Ola Holmström CFO Teleconference Wednesday February 2, 2004 at 4 P.M. Year-end report 2003.
Atlas Copco Group Q4 Results February 2, Q4 - highlights  Order growth continued  Record operating profit –All business areas above 20% operating.
Acquisition of Jostra Group GETINGE has signed an agreement to purchase 100% of the shares of Jostra A.G. GETINGE will not acquire Jostra’s former US operations.
Presentation of 2007 Annual Results Neways Electronics International N.V. 26 February 2008.
McBride plc : Interim Results 9 February 2006.
1 A Crystal Ball: How to Improve the Health Care System Tom Closson President and CEO Ontario Hospital Association NAPAN 8th Annual Conference Sunday,
Hospital/Healthcare Provider Analysis 7/9/15. HCA owns and operates approximately 166 hospitals and approximately 113 freestanding surgery centers in.
GETINGE Capital Markets Day January 30 th, GETINGE... a rapidly expanding healthcare company.
February 2, Atlas Copco Group Q4 Results February 2, 2010.
16 October The SKF Group Nine-month results 2008 Tom Johnstone, President and CEO.
INVESTOR PRESENTATION May 8, Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and.
Getinge Group. Shaping Health Care of tomorrow Net Sales10.9 billion SEK INFECTION CONTROL Production units10 Sales companies25 EXTENDED CARE Production.
Framtidens Stad Malmö, 26 november, The largest European window group in a fragmented market Clear market leader in the Nordic region Leading.
The SKF Group Half-year result, 2005 Tom Johnstone, President and CEO.
Atlas Copco Group Q3 Results October 22, Q3 - highlights  Strong order growth –Sequentially higher volumes in all regions and in most customer.
April 27, Atlas Copco Group Q1 Results April 27, 2005.
0 Teleconference 1 st Quarter 2007 Results. 1 Disclaimer This document contains “forward-looking statements”. Forward-looking statements may be identified.
July 17, Atlas Copco Group Q2 Results July 17, 2006.
Lavendon Group plc 2006 Preliminary Results Presentation March 2007.
April 26, 2007, Atlas Copco Group Q1 Results April 26, 2007.
0 15 July The SKF Group Half-year results 2008 Tom Johnstone, President and CEO.
GETINGE GROUP Year end report January – December January 2012 Johan Malmquist, CEO Ulf Grunander, CFO.
Getinge overview An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly.
26 July 05, page 1 Company Confidential Results Second Quarter 2005 and 6 months ended 30 June 2005.
Ben Noteboom, acting CEO Robert-Jan van de Kraats, CFO February 18, 2003 Fourth quarter and annual results 2002.
0 16 April The SKF Group First-quarter results 2008 Tom Johnstone, President and CEO.
NSW Perspective Dr Mary Foley Secretary, NSW Health.
16 February 06, page 1 Company Confidential Results 4Q05 and FY05 Martin De Prycker, CEO 16 February 2006.
26 October 05, page 1 Company Confidential Results Third Quarter 2005 Martin De Prycker, CEO 26 October 2005.
The SKF Group First-quarter result 2005 Tom Johnstone, President and CEO.
Atlas Copco Group Q4 Results February 14, Page 2 February 14, 2002www.atlascopco-group.com Contents  Q4 Highlights and strategic moves  Market.
Atlas Copco Group Q2 Results July 18, Page 2 July 18, 2002www.atlascopco-group.com Contents  Q2 Highlights  Market Development  Business Areas.
Giulio Mazzalupi Atlas Copco Group - Q4 Results Stockholm, February 12, 2001.
The SKF Group Half-year result 2003 Tom Johnstone President and CEO.
Opportunities in 2012 and Beyond The Way Forward Stuart Semple Director of Pharmacy and Medicines Management Barts Health NHS Trust.
Telephone conference July 13th Page 2 CEO comment to the half-year report ”During the first half of the year we achieved results before restructuring.
Telephone conference February 16 th Page 2 CEO comment to the full-year report ”The integration process following the Hamelin merger and efforts.
The Hospital & Healthsystem Association of Pennsylvania© Updated August 2015 Pennsylvania Hospital Perspective, Ten Year Trend in Inpatient and.
Telephone conference May 16th Page 2 CEO comment to the Q1 Report ”The first Quarter of 2012 was characterised by a strong recovery after the difficult.
Q1 Report 2016 Coor Service Management Mikael Stöhr, President and CEO Olof Stålnacke, CFO.
July 16, Atlas Copco Group Q2 Results July 16, 2004.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved China Artificial Disc Market to grow at 24% CAGR from 2016 to 2024.
Population Health Management segment of Healthcare Analytics Market to grow at 13% CAGR from 2017 to 2024
Interim Report January-September 2002
Alrik Danielson, President and CEO
January – September 2000 November 9, 2000
Pennsylvania Hospital Trends,
IT Solutions – Improving Timely Access to Health Care
AddLife Year-end report February, 2017
PRESENTATION UDI MIZRAHI, VP FINANCE January 2017.
Agenda Clas Ohlson in brief The sustainability agenda Our value chain
Improving Access to Subspecialty Care in an Academic Medical Center
Medical Bed Market share to grow at 5.5% CAGR from 2017 to 2024
Compensation Committee 2017 Goals – Updated
Results 4Q04 and FY04 Martin De Prycker CEO February 17, 2005
GMHC Board of Directors November 14, 2016
Mikael Stöhr, President and CEO Olof Stålnacke, CFO and IR Director
Atlas Copco Group Q3 Results October 22, 2010.
Alrik Danielson, President and CEO
20 April 2010.
The SKF Group Nine-month result 2003 Tom Johnstone President and CEO.
The SKF Group Year-end result 2003 Tom Johnstone President and CEO.
Moving Forward Together Programme Overview
GETINGE GROUP Year end report January – December January 2012
Q3 Welcome to NOTE AB (publ) – Q3 presentation
Presentation transcript:

Quality. Compassion. Care. Quality drives productivity and growth President and CEO – Thomas Berglund March 2017

A leader in European healthcare Capio today 12,400 employees (FTE) and 4.7 million patient visits in Sweden, Norway, France and Germany. From Jan 2017, Denmark added to the Group Offers a broad range of medical, surgical and psychiatric care of high quality in our hospitals, specialist clinics and primary care units Founded in 1994 in Sweden. Listed on Nasdaq Stockholm 2000-2006 and re-listed in June 2015. In the past ten years Capio has: Developed a medical strategy Driven by an empowered organization Invested in facilities and equipment to build for the future A pan-European footprint (2016) Net sales: SEK 14.1 billions 8% 38% 54% Since January 2017 present in Denmark: The acquisition of CFR Hospitaler adds sales of about MDKK 280 A leader in European healthcare Capio AB (publ) – March 2017

Experience across all care levels Capio footprint Capio footprint Sweden 1 emergency hospital 2 local hospitals 29 locations for specialist care 14 locations for psychiatric care 83 locations for primary care Nordic University hospital     Emergency hospital Norway 8 medical centers 3 specialist clinics  Local hospital Denmark 4 specialized hospitals 4 radiology units Specialist clinic France 8 emergency hospitals 10 local hospitals 3 specialist clinics 1 day surgery center Primary care unit Germany 5 general hospitals 4 specialist clinics 7 outpatient clinics (MVZ) Current market position #1 #2 #2 #3 #<15 Experience across all care levels Capio AB (publ) – March 2017

Rapid Recovery strategy delivers Modern Medicine and Rapid Recovery reducing AVLOS in France – from 8.2 to 4.5 days in Capio France on hip and knee Capio France – hip and knee prosthesis surgery Capio growth of hip and knee replacements well above market growth Continued significant AVLOS reduction for hip and knee replacements also in 2016. 10% more patients discharged within four days in 2016 compared with 2015 Total AVLOS reduction from 2011 to 2016 was -45% for Capio France Steady growth in the number of procedures performed in daycare AVLOS development hip and knee replacements 2011-2016 Rapid Recovery strategy delivers Source: French market data; Scansanté (ATIH), Swedish market data; Socialstyrelsen Capio AB (publ) – March 2017

Modern Medicine in practice Multi-modal intervention Conventional treatment Surgery Weeks Days Functional capacity Illustrative effects from Modern Medicine 2011-2016 Capio France hip and knee prosthesis surgery Earlier discharge AVLOS -45% No. of surgeries +41% No. of beds needed for the increased production -28% A well structured medical process with CPIs improves medical quality (QPI) By measuring production and resources we get KPIs that are the link to financial results A structured medical process improves quality and frees up capacity Capio AB (publ) – March 2017

eHealth is a growing part of the future I need help! Digital documentation of medical story. Supported by questions/algorithms Patient medical story Triage Different time Different place Different place Same time Same place Same time Acute hospital/ Specialist Self care DIGIPHYSICAL HEALTHCARE Agreement with Doctrin, a Swedish provider of e-health solutions. Capio has acquired a minority share to support further development Capio AB (publ) – March 2017

97.2% EPS growth and proposed dividend of SEK 0.90 Continued positive development in Nordic and Germany – France compensated for the main part of the price reduction Highlights January – December 2016 Solid development: 3.3% organic sales growth 8.8% EBITA growth 97.2% EPS growth and proposed dividend of SEK 0.90 2.7x financial leverage. Net debt at MSEK 2,872 Continued strong result growth in Nordic and Germany driven by organic sales growth and productivity improvements Strong volume growth and productivity improvements compensated for the main part of the French price reduction in 2016. Lower final yearly price reimbursement than expected and some minor strike effects impacted the fourth quarter Increased acquisition activity – new entry into Denmark and acquisition of 11 primary care centers in the West of Sweden adding yearly sales of MSEK >700 Capio AB (publ) 2017-02-10

Nordic – Acquisition of CFR Hospitaler and Backa Läkarhus Denmark added to our Nordic platform (Net sales of MDKK 288 = ~MSEK 366) - Same demographic drivers as in the rest of Europe - Increased pressure on publicly produced healthcare - Increasing waiting times Backa Läkarhus added to Capio Proximity Care in Sweden (Net sales of MSEK 370) - 11 primary care centers (incl. nine rehabilitation centers) and one light A&E center added to the west of Sweden – strengthens market leadership - now a total of more than 750,000 listed patients in Sweden Capio’s focus is on expanding work for the public sector Strong base for digitalization Acquisitions will contribute positively to group margin development 2017. Continued focus on acquisition activity Capio AB (publ) – March 2017

Tariffs for reimbursement of healthcare in France 2017 Continued pressure from the French government -2.09% vs. the 2016 tariff level – in line with Capio’s expectations New prices are valid March 1, 2017 to February 28, 2018 Full price list (price per treatment) not yet known - business mix impacting final effect Another challenging year ahead, but we are determined to fully compensate for this in 2017 Volume growth Productivity improvements Procurement Turnaround of a few lagging units Aiming for full compensation of the 2017 price reduction Capio AB (publ) – March 2017

Financial performance by segment 2013-2016 Capio Nordic Capio France Capio Germany Net sales & organic sales growth1 Net sales & organic sales growth1 Net sales & organic sales growth 7,243 7,584 6,968 6,544 5,313 4,869 5,098 4,552 5.4 4.6 3.8 4.0 3.5 2.4 2.4 2.4 2.0 2.7 0.7 1,031 1,123 1,145 1,172 1.9 Operating result (EBITA) and margin1 Operating result (EBITA) and margin1 Operating result (EBITA) and margin 371 314 287 286 283 316 7.1 6.3 6.5 6.4 262 5.6 5.3 233 4.9 5.0 4.9 4.4 74 83 3.6 3.8 52 55 1 2012 to 2014 adjusted for structural changes made in 2014. Refer to Capio Annual Report 2015 page 26 and 43. Strong development in Nordic and Germany. France burdened by price reductions Capio AB (publ) – March 2017

Group financial performance 2012-2016 Net sales & organic sales growth1 Operating result (EBITDA) and margin1 Operating result (EBITA) and margin1 13,486 14,069 12,960 12,127 10,292 1,061 972 1,001 896 4.1 818 644 3.3 592 544 7.4 7.5 7.4 7.5 2.5 437 483 4.6 2.9 7.9 4.2 4.4 2.3 4.2 4.0 Organic sales growth EBITDA growth EBITA growth EBITA growth 3.3% 2.6% 3.0% 7.0% 6.0% 6.4% 10.6% 8.8% 9.3% Mean 2012-20151 2016 Q3 2016 CAGR 2012-20151 2016 Q3 2016 CAGR 2012-20151 2016 Q3 2016 1 2012 to 2014 adjusted for the structural changes made in 2014. Refer to Capio Annual Report 2015 page 24. Current development slightly below the long-term performance Capio AB (publ) – March 2017

Capio has a clear strategy matching the needs of an ageing Europe Summary Increasing demand for healthcare Modern Medicine AVLOS, day surgery and digitalization 15% 19% 29% 60+ Age 1960 2010 2050 Time Demand driven by aging population, new treatment methods and chronic conditions Performance gaps between countries opportunity for increased productivity Modern Management Solid performance overall in line with target Empowered organization to drive change and improved efficiency Positioned for continued growth, organically as well as acquisitive growth Capio has a clear strategy matching the needs of an ageing Europe Capio AB (publ) – March 2017

www.capio.com